Searched for
CLINICAL TRIALS HUB
Why CDSCO and BEE have not kept pace with the industries they overseeCDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals. About a decade ...- Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
- Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
- Clinical research entities asked to register by April 1India's drug regulatory authority mandates all clinical research organisations to register through the SUGAM portal by April 1 to enhance t...
- India on the verge of becoming clinical trials hub, Parexel executive saysIndia is poised to become a prominent site for early-stage clinical trials, particularly amid the disruptions caused by the Russia-Ukraine ...
- India emerging as a hub for clinical trials, says Parexel"In the past, if they wanted to do clinical trials in 28 countries, India used to be 20th on the list. But, now, India started popping up a...
- DTAB recommends granting licence to manufacture, stock new drugs, jabs under clinical trialBased on the recommendation, the Drugs Controller General of India (DCGI) has sent a draft proposal to the Union Health Ministry for approv...
- Government looks to fast-track approvals for clinical trialsThe central drug regulator plans to fast track the approval process for clinical trials while ensuring that the contract research organisat...
- 'Bulk drug industry needs to be strengthened'There is a need to strengthen development of bulk drug industry in India as the country offers tremendous potential in research and develop...
- Uncertainty in regulatory regime forcing Indian firms like Biocon shift drug trials abroadBlame administrative lethargy, not judicial overreach, for regulatory vacuum, making India forgo a valuable economic activity, which raises...
- India needs to step up to be a biopharma major, says Boston Consulting Group"India offers several advantages in R&D, but it's behind," said Bart Janssens, a BCG partner and coauthor of the report.
- No more off-the-record human clinical trialsThe government has mandated all human clinical trials being done in the country to be registered with the Indian Council of Medical Researc...
- Pharma cos may trim clinical research spend as budget shrinksThe clinical research business in India, which has growing at a robust pace over the past few years, is likely to face a slowdown in 2009-1...
- Government to crack whip on errant drug companiesThe government will soon amend its drug laws to give the health ministry explicit powers to punish companies that unethically test drugs un...
- Action against Wyeth for death of infant: DGCIThe Drug Controller General of India (DCGI) has said that action will be taken against the guilty for the death of an infant during a clini...
- Clinical Research to become Rs 10,000 Cr industry by 2010Clinical Research in India is expected to grow to a Rs 10,000 crore industry by 2010 spelling an opportunity of 50,000 jobs within India.Th...
- 'India emerging as pharma research hub'Minister for Science & Technology Kapil Sibal believes India is emerging as a global pharma research hub.
- Barings buys stake in Siro ClinpharmBarings Private Equity Partners has picked up a stake in Siro Clinpharm, a Mumbai-based clinical research organisation (CRO) for an undiscl...
Load More
